Chul-Kee Park Selected Research

Chul-Kee Park Research Topics

Disease

72	Neoplasms (Cancer) 04/2024 - 01/2008
64	Glioblastoma (Glioblastoma Multiforme) 05/2024 - 01/2009
39	Glioma (Gliomas) 05/2024 - 06/2009
16	Brain Neoplasms (Brain Tumor) 01/2024 - 01/2008
12	Meningioma (Meningiomas) 01/2023 - 07/2006
10	Oligodendroglioma 05/2024 - 02/2008
8	Astrocytoma (Pilocytic Astrocytoma) 05/2024 - 04/2012
7	Disease Progression 01/2024 - 11/2013
5	Neurocytoma 04/2024 - 11/2007
5	Carcinogenesis 01/2023 - 01/2014
4	Ependymoma 01/2023 - 12/2017
3	Neoplasm Metastasis (Metastasis) 01/2016 - 01/2012
2	Hemangiopericytoma 01/2022 - 05/2018
2	Lymphoma (Lymphomas) 03/2020 - 10/2013
2	Medulloblastoma 03/2011 - 01/2008
1	Acute Kidney Injury (Acute Renal Failure) 01/2024
1	Kidney Diseases (Kidney Disease) 01/2024
1	Brain Abscess (Abscess, Brain) 12/2023
1	Suppuration 12/2023
1	Intracranial Aneurysm (Cerebral Aneurysm) 10/2023
1	Aneurysm (Aneurysms) 10/2023
1	Hyperlactatemia 10/2023
1	Infections 01/2022
1	Bacterial Meningitis 01/2022
1	Solitary Fibrous Tumors 01/2022
1	Microsatellite Instability 01/2022
1	Germinoma 10/2021

Drug/Important Bio-Agent (IBA)

30	Temozolomide (Temodar)FDA LinkGeneric 04/2023 - 07/2011
18	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 05/2024 - 11/2012
14	Biomarkers (Surrogate Marker)IBA 10/2023 - 07/2007
10	MethyltransferasesIBA 01/2019 - 08/2009
9	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 02/2011
9	AcidsIBA 02/2020 - 10/2009
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2008
6	RNA (Ribonucleic Acid)IBA 04/2024 - 05/2018
5	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2022 - 01/2017
5	Bevacizumab (Avastin)FDA Link 01/2019 - 05/2013
4	ErbB Receptors (EGF Receptor)IBA 01/2023 - 01/2013
4	Mucin-1 (CA 15-3 Antigen)IBA 01/2023 - 12/2010
4	Fluorescent Dyes (Fluorescent Probes)IBA 01/2023 - 06/2020
4	EnzymesIBA 02/2020 - 01/2014
4	O-(6)-methylguanineIBA 01/2019 - 02/2011
3	Peptides (Polypeptides)IBA 10/2022 - 03/2014
3	VimentinIBA 10/2021 - 12/2010
3	Alkylating AgentsIBA 12/2019 - 02/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 07/2006
3	N-acetoacetyl-N-deacetylcolchicineIBA 10/2016 - 01/2014
3	Indicators and Reagents (Reagents)IBA 10/2016 - 08/2006
3	alpha-hydroxyglutarateIBA 01/2016 - 12/2013
3	Cisplatin (Platino)FDA LinkGeneric 07/2011 - 01/2009
3	NimustineIBA 07/2011 - 01/2009
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2024 - 10/2023
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023 - 11/2019
2	Alanine Transaminase (SGPT)IBA 01/2023 - 11/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2018
2	Histone Deacetylase InhibitorsIBA 01/2019 - 02/2017
2	LigandsIBA 01/2019 - 01/2018
2	Contrast MediaIBA 01/2018 - 03/2015
2	Branched-Chain Amino AcidsIBA 12/2017 - 10/2016
2	theasinensin AIBA 02/2017 - 10/2014
2	protoporphyrin IXIBA 08/2015 - 09/2014
2	A-Form DNA (A-DNA)IBA 03/2015 - 02/2011
2	TensinsIBA 03/2014 - 01/2013
2	Glial Fibrillary Acidic ProteinIBA 03/2014 - 01/2008
2	CamptothecinIBA 02/2012 - 06/2009
2	belotecanIBA 02/2012 - 06/2009
1	Oxygen (Dioxygen)IBA 01/2024
1	CreatinineIBA 01/2024
1	Proto-Oncogene Proteins B-rafIBA 01/2024
1	16S Ribosomal RNAIBA 12/2023
1	ORALIT (ORS)IBA 10/2023
1	fatostatinIBA 03/2023
1	Monoclonal AntibodiesIBA 01/2023
1	GC1118IBA 01/2023
1	peptide AIBA 10/2022
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 10/2022
1	N-end cysteine peptide tumor-homing peptideIBA 10/2022
1	SiliconIBA 10/2022
1	HomocysteineIBA 04/2022
1	pyridineIBA 04/2022
1	Circular RNAIBA 01/2022
1	ElementsIBA 01/2022
1	Ribosomal DNA (rDNA)IBA 01/2022
1	Hormones (Hormone)IBA 10/2021
1	Protons (Proton)IBA 05/2021
1	N 30IBA 03/2021

Therapy/Procedure

33	Radiotherapy 01/2024 - 10/2008
17	Therapeutics 01/2024 - 11/2007
17	Drug Therapy (Chemotherapy) 01/2023 - 01/2009
12	Chemoradiotherapy 01/2020 - 02/2011
7	Adjuvant Radiotherapy 04/2023 - 11/2013
4	Immunotherapy 01/2022 - 01/2016
3	Anesthesia 01/2024 - 03/2019
3	Lasers (Laser) 01/2024 - 01/2009
3	Craniotomy 10/2023 - 10/2007
3	Combined Modality Therapy 05/2019 - 03/2013
2	Aftercare (After-Treatment) 06/2019 - 04/2012
2	Adjuvant Chemotherapy 07/2014 - 07/2011
2	Ligation 02/2013 - 10/2012
1	General Anesthesia 03/2022